Abstract
Ductal carcinoma in situ (DCIS) is a pre-invasive form of breast cancer where neoplastic luminal cells are confined to the ductal tree. While as many as 70% of DCIS cases will remain indolent, most women are treated with surgery, often combined with endocrine and radiotherapies. Overtreatment is therefore a major issue, demanding new methods to stratify patients. Somewhat paradoxically, the neoplastic cells in DCIS are genetically comparable to those in invasive disease, suggesting the tumour microenvironment is the driving force for progression. Clinical and mechanistic studies highlight the complex DCIS microenvironment, with multiple cell types competing to regulate progression. Here, we examine recent studies detailing distinct aspects of the DCIS microenvironment and discuss how these may inform more effective care.
Original language | English |
---|---|
Pages (from-to) | 326-338 |
Number of pages | 13 |
Journal | Trends in cancer |
Volume | 9 |
Issue number | 4 |
Early online date | 2 Feb 2023 |
DOIs | |
Publication status | Published - 1 Apr 2023 |
Keywords
- Female
- Humans
- Carcinoma, Intraductal, Noninfiltrating/therapy
- Tumor Microenvironment
- Breast Neoplasms/genetics
- ductal carcinoma in situ
- invasion
- biomarkers
- breast cancer
- tumour microenvironment
ASJC Scopus subject areas
- Oncology
- Cancer Research